Cytomegalovirus-induced infectious mononucleosis-like syndrome in a rheumatoid arthritis patient treated with methotrexate and infliximab

Intern Med. 2010;49(10):937-40. doi: 10.2169/internalmedicine.49.3188. Epub 2010 May 14.

Abstract

We report a patient with rheumatoid arthritis (RA) who developed cytomegalovirus (CMV)-induced infectious mononucleosis-like syndrome (IMLS) while being treated with methotrexate and infliximab. She suddenly developed intermittent high fever and general fatigue with liver dysfunction, remarkable lymphocytosis and laboratory data suggestive of CMV reactivation. Her clinical symptoms quickly improved after the cessation of methotrexate and infliximab without the use of anti-viral drugs such as ganciclovir. CMV-induced IMLS might be a cause of persistent fever in RA patients, particularly when biologics are used for treatment.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / etiology*
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Infectious Mononucleosis / diagnosis
  • Infectious Mononucleosis / etiology*
  • Infliximab
  • Methotrexate / adverse effects*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Methotrexate